Related Articles
Temozolomide inhibits cellular growth and motility via targeting ERK signaling in glioma C6 cells
TRIM31 enhances chemoresistance in glioblastoma through activation of the PI3K/Akt signaling pathway
Estrogen receptor β agonist enhances temozolomide sensitivity of glioma cells by inhibiting PI3K/AKT/mTOR pathway
BKM120 sensitizes C6 glioma cells to temozolomide via suppression of the PI3K/Akt/NF‑κB/MGMT signaling pathway
Sirtuin 1 knockdown inhibits glioma cell proliferation and potentiates temozolomide toxicity via facilitation of reactive oxygen species generation